Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gracey

Showing results (271-280 of 273) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 273 results.
Clinical & Translational Immunology|July 23, 2021
Erratum: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastomaRebecca C Abbott, Daniel J Verdon, Fiona M Gracey, et al.
Clinical & Translational Immunology|May 12, 2021
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastomaRebecca C Abbott, Daniel J Verdon, Fiona M Gracey, et al.
Plos One|February 24, 2023
Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort studyJack E Heron, Hamish McManus, Tobias Vickers, et al.
Pageof 28

Showing results (271-280 of 273) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 273 results.
Clinical & Translational Immunology|July 23, 2021
Erratum: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastomaRebecca C Abbott, Daniel J Verdon, Fiona M Gracey, et al.
Clinical & Translational Immunology|May 12, 2021
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastomaRebecca C Abbott, Daniel J Verdon, Fiona M Gracey, et al.
Plos One|February 24, 2023
Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort studyJack E Heron, Hamish McManus, Tobias Vickers, et al.
Pageof 28